0001490109-17-000001.txt : 20170825 0001490109-17-000001.hdr.sgml : 20170825 20170825161420 ACCESSION NUMBER: 0001490109-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170825 DATE AS OF CHANGE: 20170825 EFFECTIVENESS DATE: 20170825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carmot Therapeutics Inc. CENTRAL INDEX KEY: 0001490109 IRS NUMBER: 261872684 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-293514 FILM NUMBER: 171052126 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 510-828-0102 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0708 D LIVE 0001490109 Carmot Therapeutics Inc. 409 ILLINOIS STREET SAN FRANCISCO CA CALIFORNIA 94158 510-828-0102 DELAWARE None None Corporation true Daniel A. Erlanson 409 Illinois Street San Francisco CA CALIFORNIA 94158 Executive Officer Director Stig K. Hansen 409 Illinois Street San Francisco CA CALIFORNIA 94158 Executive Officer Director Tim Kutzkey 1700 Owens Street Suite 595 San Francisco CA CALIFORNIA 94158 Director Larry Lasky 1700 Owens Street Suite 595 San Francisco CA CALIFORNIA 94158 Director Aetna Wun Trombley 409 Illinois Street San Francisco CA CALIFORNIA 94158 Director Biotechnology Decline to Disclose 06b false 2017-08-11 false true false 0 15374764 10795943 4578821 false 4 0 0 0 false Carmot Therapeutics Inc. /s/ Stig K. Hansen Stig K. Hansen Chief Executive Officer 2017-08-25